Tao Lu

机构：China Pharmaceutical University, Beijing University of Chinese Medicine, Zunyi Medical University, Capital Medical University, Affiliated Hospital of Zunyi Medical College · ORCID：0000-0002-8247-8387

发表论文 171 篇 · 总被引 10368 次 · h-index 31

代表论文

• The association among individual gray matter volume of frontal-limbic circuitry, fatigue susceptibility, and comorbid neuropsychiatric symptoms following COVID-19 (2025 · NeuroImage · 被引 6)
• Targeting polyamine metabolism and ferroptosis enhances the efficacy of KRAS-targeted therapy depending on KEAP1 status (2025 · Nature Communications · 被引 5)
• Efficacy and safety of RC48 in combination with PD-1 inhibitors for the treatment of locally advanced or metastatic urothelial carcinoma: a single-center, real-world study (2025 · Discover Oncology · 被引 5)
• Early corticospinal tract sub-pathway lesion load and integrity predict post-stroke motor outcomes (2025 · Frontiers in Human Neuroscience · 被引 4)
• Mechanistic study on HuaganJiedu decoction in treating hepatitis B based on multi-omics analysis of network pharmacology, metabolomics, and transcriptomics (2025 · Phytomedicine · 被引 3)
• Sources and Metabolism of D-Amino Acids and Their Roles as Biomarkers in Kidney Disease: A Review (2025 · Medical Science Monitor · 被引 2)